Easyjet profits recover

EASYJET yesterday trumpeted its success in being one of the few European airlines to make profits last year, even though they plummeted 65%.

Read Full Story

Have Your Shout

Marks & Spencer's chief executive Stuart Rose names Morrison's Marc Bolland as new boss

MORRISONS boss Marc Bolland, Marks & Spencer's new boss, is expected to broaden the firm's horizons to embrace new products and international markets.

Read Full Story

Have Your Shout

Chocolate blocker

ITALIAN chocolate firm Ferrero and confectionery group Cadbury could team up to fend off hostile bidder Kraft Foods.

Read Full Story

Have Your Shout

Get posting in the Star Forums!

You can join the debate and post your own views in the lively Daily Star Forums!

GLAXO'S SWINE FLU WIN

ABOVE: Boost for sales at GlaxoSmithKline

7th October 2009

By Daily Star Reporter

THE global swine flu pandemic and China’s efforts to prevent children catching measles and mumps are set to boost vaccine sales at drug giant GlaxoSmithKline.

Glaxo has won 22 more government orders for 149 m extra doses of its H1N1 swine fl u vaccine in the past two months, giving it 440 m doses on order.

Glaxo has said it expected to sell the vaccine for about the same price as seasonal flu shots, about £5 a dose, implying total booked orders of about £2.2 bn.

It also has several deals with the US government to supply pandemic products worth an extra $250 m and is in talks with other governments.

Glaxo is forming a £41.2 m joint venture with China’s Jiangsu Walvax Biotech Company to make paediatric vaccines against measles, mumps and rubella in China.

» MORE 'IT'S THE BUSINESS' HERE...

Share @: